Matthew Tremblay
Impact in
-
- Multiple Sclerosis Research Studies
-
- Peripheral Neuropathies and Disorders
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Multiple Sclerosis Research Studies 7
-
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Christopher M. Acker (2 shared papers)Peter Davies (2 shared papers)Sarah D. Schlatterer (1 shared paper)Ilya Kister (1 shared paper)Jeffrey M. Gelfand (3 shared papers)Jennifer Graves (2 shared papers)Carolyn Bevan (2 shared papers)Riley Bove (2 shared papers)
- Journals
- Neurology (3 papers)Journal of Alzheimer s Disease (2 papers)Neurogenetics (1 paper)Vaccines (1 paper)Journal of Neurology (1 paper)
- Partner nations
- United StatesSwitzerlandMexico
In The Last Decade
Matthew Tremblay
11 papers receiving 318 citations
Peers
Comparison fields: 5 of 65
- Pathology and Forensic Medicine 109
- Neurology 81
- Hematology 47
- Neurology 33
- Physiology 87
Countries citing papers authored by Matthew Tremblay
This map shows the geographic impact of Matthew Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Tremblay more than expected).
Fields of papers citing papers by Matthew Tremblay
This network shows the impact of papers produced by Matthew Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Tremblay. The network helps show where Matthew Tremblay may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Tremblay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 106 | |
| 2 | 2010 | 85 | |
| 3 | 2011 | 55 | |
| 4 | 2020 | 29 | |
| 5 | 2015 | 20 | |
| 6 | 2017 | 12 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2017 | 1 | |
| 11 | 2017 | 1 | |
| 12 | 2020 | 0 |
About Matthew Tremblay
Matthew Tremblay is a scholar working on Pathology and Forensic Medicine, Infectious Diseases, Molecular Biology, Hematology and Neurology, having authored 12 papers that have together received 323 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Polyomavirus and related diseases (2 papers), Immunotherapy and Immune Responses (2 papers), Metabolism and Genetic Disorders (1 paper), Digital Imaging for Blood Diseases (1 paper) and Kruppel-like factors research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (109 citations), Neurology (81 citations), Hematology (47 citations), Neurology (33 citations) and Physiology (87 citations). Matthew Tremblay has collaborated with scholars based in United States, Switzerland and Mexico. Frequent co-authors include Christopher M. Acker, Peter Davies, Sarah D. Schlatterer, Ilya Kister, Jeffrey M. Gelfand, Jennifer Graves, Carolyn Bevan, Riley Bove, Mark J. Pletcher and Elizabeth Crabtree‐Hartman. Their work appears in journals such as Neurology, Journal of Alzheimer s Disease, Neurogenetics, Vaccines and Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.